Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18
It intentionally combines peptides with complementary actions so the body can move from injury and inflammation toward repair and resilience
It works better for musculoskeletal injuries like tendons, ligaments, and muscles
Seiwerth and colleagues (Inflammopharmacology, 1999) documented effects on angiogenic growth factor pathway signalling, and subsequent work has expanded characterisation to include VEGF receptor 2 upregulation, endothelial cell migration in capillary-formation assays, and improved healing in ischemia-reperfusion preparations
Safety Profile: What Clinical Trials Actually Documented Across six clinical trials involving approximately 900 participants, AOD-9604 produced no treatment-related serious adverse events, no immunogenic response, no IGF-1 elevation, and no adverse cardiovascular or metabolic signals
They're sold in a legal gray zone as: "Research chemicals" "For laboratory use only" "Not for human consumption" Yet thousands of people are injecting them
US$ 21.81
US$ 20.10
US$ 24.42
US$ 21.60
US$ 27.26